Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.56M | -7.95M | -6.38M | -7.48M | -8.53M |
| Total Depreciation and Amortization | 273.20K | 270.30K | 268.80K | 271.90K | 273.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.32M | 2.72M | 4.07M | 2.49M | 826.20K |
| Change in Net Operating Assets | 3.22M | -255.50K | -3.70M | -3.70M | -3.70M |
| Cash from Operations | -4.74M | -5.21M | -5.74M | -8.42M | -11.13M |
| Capital Expenditure | -24.20K | -15.00K | -6.00K | -5.70K | -5.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.20K | -15.00K | -6.00K | -5.70K | -5.40K |
| Total Debt Issued | 3.00M | 1.50M | -- | -- | -- |
| Total Debt Repaid | -60.60K | -69.70K | -78.80K | -85.30K | -91.80K |
| Issuance of Common Stock | 12.24M | 16.79M | 21.34M | 20.22M | 19.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -529.80K | -835.00K | -1.14M | -1.10M | -1.06M |
| Cash from Financing | 9.60M | 11.43M | 13.28M | 12.57M | 11.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.83M | 6.20M | 7.53M | 4.15M | 637.00K |